These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14054214)

  • 21. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 22. Verrucous papillomatous lesion of post-kala-azar dermal leishmaniasis: fine needle aspiration diagnosis of an unusual presentation.
    Bhadani PP; Sen R; Singh RK
    Acta Cytol; 2007; 51(2):252-4. PubMed ID: 17425218
    [No Abstract]   [Full Text] [Related]  

  • 23. Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs.
    Nogueira FS; Moreira MA; Borja-Cabrera GP; Santos FN; Menz I; Parra LE; Xu Z; Chu HJ; Palatnik-de-Sousa CB; Luvizotto MC
    Vaccine; 2005 Sep; 23(40):4805-10. PubMed ID: 16011864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Our experience in the treatment of kala-azar].
    de YTURRIAGA E; GONZALEZ BOTELLA S
    Acta Pediatr Esp; 1950 May; 8(89):569-76. PubMed ID: 15418997
    [No Abstract]   [Full Text] [Related]  

  • 25. An unusual presentation of post-kala-azar dermal leishmaniasis.
    Ramesh V; Kumar J; Salotra P
    Trop Doct; 2007 Jul; 37(3):172-3. PubMed ID: 17716510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M; Majumder HK; Sundar S; Bhaduri AN
    Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kala-azar; with special studies of bone marrow and lymph nodes.
    SENTER WJ; SUTKER H; GARVER HE
    Am J Med; 1949 Nov; 7(5):694-8. PubMed ID: 15396071
    [No Abstract]   [Full Text] [Related]  

  • 28. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
    J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
    Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB; Yang CM; Zhang CJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract]   [Full Text] [Related]  

  • 31. [KALA-AZAR IN A GERMAN CHILD].
    REIMERS E; SCHOEN H; SPIESS H
    Monatsschr Kinderheilkd (1902); 1965 Mar; 113():100-2. PubMed ID: 14271442
    [No Abstract]   [Full Text] [Related]  

  • 32. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 33. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observations on the degree of splenic and hepatic enlargement in kala-azar and tropical splenomegaly.
    CHATTERJEE SN
    J Indian Med Assoc; 1955 Nov; 25(11):435-6. PubMed ID: 13278555
    [No Abstract]   [Full Text] [Related]  

  • 35. Stilbamidine in the treatment of Chinese kala-azar, with especial reference to antimony resistant and antimony hypersensitive cases.
    CHUNG HL; CHOW HK; CHANG A; TSAO YP
    Chin Med J; 1951; 69(3-4):171-84. PubMed ID: 14831172
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoelectrophoretic analysis of serum proteins of patients affected by kala-azar.
    Priolisi A; Giuffrè L
    Pathol Microbiol (Basel); 1967; 30(2):215-21. PubMed ID: 4166305
    [No Abstract]   [Full Text] [Related]  

  • 37. [Morphological aspects of the blood protein disorder due to kala-azar].
    ANDRADE ZA
    Rev Assoc Med Bras; 1959 Dec; 5():413-21. PubMed ID: 13793495
    [No Abstract]   [Full Text] [Related]  

  • 38. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
    Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V
    Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [LEISHMANIASIS AS ENCOUNTERED IN FRANCE. CLINICAL AND THERAPEUTIC ASPECTS].
    SCHNEIDER J
    Rev Prat; 1964 Mar; 14():1149-63. PubMed ID: 14146424
    [No Abstract]   [Full Text] [Related]  

  • 40. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
    Ramesh V
    Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.